The Effects of North Carolina’s Prescription Drug Monitoring Program on the Prescribing Behaviors of the State’s Providers

Abstract State-level prescription drug monitoring programs (PDMPs) show promise as a key strategy to respond to the epidemic of the misuse and abuse of controlled substances (CS), particularly opioid analgesics, in the United States. Undocumented concerns have been expressed that these PDMPs may have a “chilling effect” on providers’ willingness to prescribe these substances to their patients. Using data from North Carolina’s PDMP for the 3-year period from 2009 through 2011, we examined whether rapid increases in (1) the number of providers who queried the system, and (2) the number of days on which they queried it, would be related to their prescribing practices in regards to CS. We hypothesized that neither marker of PDMP utilization would be associated with a decrease in either patients receiving CS prescriptions or CS prescriptions filled. We found no association between either of these variables and the number of patients who filled prescriptions for CS or the number of prescriptions for CS filled. However, we did find a slight positive relationship between the growth in the utilization of the PDMP and the number of prescriptions filled for opioid analgesics. Concerns that PDMPs may constrain prescribing behavior with regards to CS are not supported.

[1]  L. Nelson,et al.  Prescription Drug Abuse: Insight Into the Epidemic , 2010, Clinical pharmacology and therapeutics.

[2]  Julie A. Worley Prescription Drug Monitoring Programs, a Response to Doctor Shopping: Purpose, Effectiveness, and Directions for Future Research , 2012, Issues in mental health nursing.

[3]  Leonard J Paulozzi,et al.  Prescription drug monitoring programs and death rates from drug overdose. , 2011, Pain medicine.

[4]  Prescription Monitoring Programs: Striking the Balance Between Medical Use and Diversion , 2011 .

[5]  Michael C. Brody,et al.  Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain , 1994, Pain.

[6]  Grant M. Carrow,et al.  Pain management and prescription monitoring. , 2002, Journal of pain and symptom management.

[7]  D. Carr,et al.  Pain Management: A Fundamental Human Right , 2007, Anesthesia and analgesia.

[8]  Adam J. Atherly,et al.  Prescription Opioid Usage and Abuse Relationships: An Evaluation of State Prescription Drug Monitoring Program Efficacy , 2009, Substance abuse : research and treatment.

[9]  Andrea M. Garcia State Laws Regulating Prescribing of Controlled Substances: Balancing the Public Health Problems of Chronic Pain and Prescription Painkiller Abuse and Overdose , 2013, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

[10]  Lewis S. Nelson,et al.  Medication reconciliation for controlled substances--an "ideal" prescription-drug monitoring program. , 2012, The New England journal of medicine.

[11]  S. Schnoll,et al.  Do prescription monitoring programs impact state trends in opioid abuse/misuse? , 2012, Pain medicine.

[12]  L. Holland,et al.  An Evaluation of Prescription Drug Monitoring Programs , 2006 .

[13]  P. Christo,et al.  The influence of prescription monitoring programs on chronic pain management. , 2009, Pain physician.

[14]  S. Fishman,et al.  Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. , 2004, Pain medicine.

[15]  L. Simon RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH , 2012 .

[16]  K. Williams,et al.  Awareness and Utilization of a Prescription Monitoring Program Among Physicians , 2011, Journal of pain & palliative care pharmacotherapy.

[17]  P. Hardigan,et al.  Attitudes of Florida Pharmacists Toward Implementing a State Prescription Drug Monitoring Program for Controlled Substances , 2011, Journal of managed care pharmacy : JMCP.